Loading
A phase 3 trial of Aspirin, Dexamethasone and Diethylstilbestrol in Prostate cancer, run by St. Bartholomew's Hospital, completed.
Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer is a phase 3 interventional study registered as NCT00316927 by St. Bartholomew's Hospital, with 260 participants recorded, started 2002-12. Interventions recorded: acetylsalicylic acid, dexamethasone, diethylstilbestrol. Conditions recorded: Prostate Cancer.
Linked to the drug Diethylstilbestrol because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Aspirin, Prostate cancer and the tag pipeline.
Shares Dexamethasone, Prostate cancer and the tag pipeline.
Shares Dexamethasone, Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Dexamethasone and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/